| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Relay Therapeutics, Inc. (RLAY) has 7 insiders with recent SEC Form 4 filings, including 0 buys and 16 sells. RLAY is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.45M | $21.47M | - | |
| Pres | 420.0K | $6.22M | - | |
| Other | 371.5K | $5.50M | - | |
| Other | 276.6K | $4.10M | - | |
| CFO | 215.7K | $3.19M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 27, 2022 | Adams Brian72 | Chief Legal Officer | Sell | 300 | $20.31 | $6,093.00 | -0.5% | +17.9% | -32.7% | |
| Jun 27, 2022 | Bergstrom Donald A75 | President, R&D | Sale+OE | 8,999 | $20.03 | $180,289.69 | -4.7% | +17.9% | -32.7% | |
| May 2, 2022 | Bergstrom Donald A75 | President, R&D | Sale+OE | 14,811 | $24.74 | $366,367.27 | -7.4% | -27.0% | -57.8% | |
| Apr 28, 2022 | Adams Brian72 | Chief Legal Officer | Sell | 708 | $25.57 | $18,103.56 | -1.1% | -14.6% | -55.1% | |
| Apr 28, 2022 | Porter Andy77 | Chief Administrative Officer | Sell | 435 | $25.57 | $11,122.95 | -0.9% | -14.6% | -55.1% | |
| Apr 28, 2022 | Catinazzo Thomas71 | Chief Financial Officer | Sell | 725 | $25.57 | $18,538.25 | -1.3% | -14.6% | -55.1% | |
| Apr 14, 2022 | Patel Sanjiv74 | President And CEO | Sale+OE | 84,000 | $31.42 | $2,639,280.00 | -6.2% | -37.0% | -43.3% | |
| Apr 1, 2022 | Bergstrom Donald A75 | President, R&D | Sale+OE | 18,000 | $30.32 | $545,760.00 | -16.0% | -47.0% | -47.9% | |
| Mar 29, 2022 | Porter Andy77 | Chief Administrative Officer | Sell | 294 | $29.87 | $8,781.78 | -0.6% | -42.2% | -50.4% | |
| Mar 29, 2022 | Catinazzo Thomas71 | Chief Financial Officer | Sell | 282 | $29.87 | $8,423.34 | -0.5% | -42.2% | -50.4% |